This is Vol.77 Newsletter for July 2026.
July 2026 reflects a rapidly evolving biopharma and healthcare landscape shaped by global market expansion, pricing dynamics, and accelerating AI integration. Korea’s biopharmaceutical exports reached record levels, while global pricing policies and flexible reimbursement systems introduced new complexity in market access strategies. At the same time, AI is expanding beyond drug discovery into clinical development, workflow optimization, and real-world implementation, alongside growing demand for next-generation platforms such as ADCs, TPD, and bispecifics. These shifts highlight a clear transition toward execution-driven competitiveness, where clinical validation, regulatory strategy, and commercialization capabilities are increasingly critical to global success.